, will become president of the company effective
February 9, 2006. Grompe is widely acknowledged as one of the world's foremost
liver and stem cell experts," stated Stephen Chang, Ph. Grompe has authored or co-authored
99 peer-reviewed articles and 32 reviews , book chapters and
editorials.

biophysical rearing

in mechanical
engineering and astronautical sciences from Northwestern University.
6,12,708 on liver regeneration using pancreatic cells.

plasmid rearing

MultiCell Appoints Leading Stem Cell Expert to its Scientific Advisory Board

transpiration biophysical

D.
"Biotechnology is poised to have a huge impact on the production of clean
and renewable energy and on the development of environmentally benign
industrial processes," said Dr.
Dr.S.
Dr. Liver stem cells may play a key role in
transplantation for tissue regeneration as well as other diagnostic
and therapeutic applications. MultiCell
believes its stem cell technique is unique within the cell therapy
market.

rearing 43rd

, Synthetic Genomics, Inc.
Venter and Hamilton O.

transpiration biophysical

Craig Venter, Ph. Patrinos is well known for his leading role in the development of the
United States government-funded Human Genome Project helping to guide the
historic sequencing of the human genome to completion, a feat which was
announced in a White House ceremony in 2000.

As part of his leadership in the
Human Genome Project, Dr., President
of MultiCell. Grompes' recent honors include the E.

43rd microbe

Craig Venter commented "While still only less than a
year old, Synthetic Genomics , like the field of science in which it is
situated, is a young, dynamic, and growing company.
Dr. Patrinos also led the expanded DOE component of the USGCRP to
attack the principal uncertainties of climate change prediction. was founded in 2005 to develop and commercialize
synthetic biology . He has been licensed to practice medicine in West Germany
and the European Community since 1983 and became a United States MD in
1984.com
The matters set forth in this press release are forward -looking
statements within the meaning of the "safe harbor" provisions of the
Private Securities Litigation Reform Act of 1995.

symposia faseb

D.D.

biologists 43rd

"
Dr. Patrinos is the recipient of numerous award and honorary degrees
including three Presidential Rank Awards and two Secretary of Energy Gold
Medals, as well as an honorary doctorate from the National Technical
University of Athens.
MultiCell holds a patent on novel strategies for isolation of
adult human liver stem cells.

chobe zoology

The use of liver stem cells to treat
diseases, such as Hepatitis C, may greatly enhance quality of life and
avoid the need for costly whole organ liver transplantation.

bioscience microbes

Ari's rare combination of breadth and depth of knowledge in areas
affecting environment and energy, along with his solid, steadfast leadership
style make him an ideal person to help drive the business and science goals of
Synthetic Genomics. Patrinos also developed and launched
the DOE's Genomes to Life Program (GTL), a research program dedicated to
developing technologies to understand and use the diverse capabilities of
microbes for innovative solutions to DOE energy and environmental mission
challenges. We
welcome his invaluable guidance as we establish a stem cell panel on
the Scientific Advisory Board to help plan the future of MultiCell ."
Dr.

symposia plasmid

Synthetic Genomics, Inc.D. From 1987-1991 he
was a Genetics Fellow at Baylor College of Medicine in Houston, Texas.

chobe radiations

Dr.

About Synthetic Genomics, Inc. In 1987 he completed a Pediatric Residency at the
Oregon Health Sciences University, Portland, Oregon. These
forward-looking statements are subject to risks and uncertainties that
may cause actual results to differ materially.

radiations eger

Patrinos Leaves Department of Energy Office of Science to take a Top Role at
Synthetic Genomics

ROCKVILLE, Md. As part of his duties there, Dr.
Founder and CEO , J."
In his role as president, Dr. The
initial focus of the research at the Company is on ethanol and hydrogen
production. (OTCBB:MUCL), a leading supplier of non-tumorigenic immortalized
human hepatocytes, announced today that it has appointed Markus
Grompe, MD to the newly formed Stem Cell Panel of its Scientific
Advisory Board. Dr.
For information about MultiCell call 401 -738-7560 or see
www. These risks are
detailed from time to time in the Company's periodic reports filed
with the Securities and Exchange Commission including the Company's
Annual Report, Quarterly Reports and other periodic filings. These
forward-looking statements speak only as of the date hereof .

symposia biovision

By leveraging the vast stores of genomic sequence data, the
Company hopes to integrate its novel processes to design, build, and test
desired outputs from synthetic organisms. Patrinos
has represented DOE on the Interagency Program on Global Change Research, and
on other interagency and international bodies dealing with biological and
environmental issues. Dr. Grompe is a Diplomate of the American Board of Human Genetics,
a member of the American Society for Investigative Pathology, a member
of the Society for Inborn Metabolic Disease, a member of the Western
Society for Pediatric Research , a member of the Society for Pediatric
Research, a member of the American Society for Human Gene Therapy, and
a member of the International Society for Stem Cell Research.
A native of New Zealand , he received his education at the
University of Ulm School of Medicine, Ulm, West Germany and was a
visiting student at the University of Oregon Health Sciences Center in
Portland, Oregon.

symposia transpiration

He was one of the original architects of the U.
Dr.

transpiration systematics

In addition to his expertise in human and microbial genomics, Dr. Dr.
Grompe was Associate Editor on the Editorial Board of the American
Journal of Human Genetics from 1996 to 1998.

zoology plasmid

From 1983 - 1984 he was a
Research Assistant in the Department of Clinical Physiology of the
University of Ulm. Mead Johnson Award for
research in Pediatrics in 2002 and the Award of Merit from the Fanconi
Anemia Research Fund in 2002.

lipids rearing

As part of our aggressive
strategy to advance this complex area of research and the commercial
opportunities it presents , we are pleased that Ari Patrinos will become
president. Patrinos. Patrinos, a native of Greece, received his undergraduate degree from
the National Technical University of Athens and a Ph.
"Dr. He also
serves on the American Society for Human Gene Therapy Committee on
Stem Cells; the NIH Beta cell consortium external advisory pane; the
NIH Study Section on Gene Therapy and Inborn Errors (Chairperson); the
March of Dimes Research grant review panel; the Society for Pediatric
Research , E.

biologists 43rd

, and dedicated to developing and
commercializing synthetic biology advances in energy fields , announced today
that Aristides Patrinos, Ph. Patrinos joins Synthetic Genomics from the Department of Energy
(DOE)'s Office of Science where he was the associate director of the Office of
Biological and Environmental Research. Patrinos will help shape the research and
business direction at the Company . Patrinos helped create the DOE's Joint Genome
Institute (JGI) in 1997 to unite the expertise and resources in genome
mapping, DNA sequencing, technology development, and information sciences
pioneered at four DOE genome centers. The Company is applying recent scientific advances,
including newly discovered genetic sequences of novel photosynthetic and
metabolic pathways, to execute various life functions within a synthetically
devised organism.'s initial focus will be on
new approaches to biological energy production. Mead Johnson Award Selection Committee; and the Board of
Directors of the International Society for Stem Cell Research.

microbe chobe

He is Board certified in Clinical Genetics, Biochemical and Molecular
Genetics.

rearing thymallus

Dr. Smith, MD, are developing synthetic organisms with the
hope that they could be engineered into modular "cassette" based systems to
execute specific functions using reprogrammed cells as bio-factories. Dr. He is a
Fellow of the American Association for the Advancement of Science (AAAS), a
Fellow of the American Meteorological Society, a Member of the American
Geophysical Union, a Member of the American Society of Mechanical Engineers,
and a Member of the Greek Technical Society.
Synthetic Genomics, Inc. The
Company disclaims any intent or obligation to update these
forward-looking statements.

zoology biovision

, the
company founded by J.
Patrinos directed research activities including the DOE human and microbial
genome programs, structural biology, nuclear medicine and health effects,
global environmental change, and basic research underpinning DOE's
environmental restoration effort. He holds U. Patent No. Grompe has taught in the Department of Molecular and Medical
Genetics and the Department of Pediatrics, Oregon Health Sciences
University, Portland, Oregon since 1991 . Obtaining stem cells from adult tissues avoids the ethical and
contamination issues often associated with embryonic stem cells.multicelltech.

grayling mycology

S. These breakthroughs present unprecedented opportunities that
could restructure and revolutionize industries including energy, industrial
organic compounds , pharmaceuticals, CO2 sequestration, fine chemicals, and
environmental remediation.

Business Editors/Health/Medical Writers

SAN DIEGO----MultiCell Technologies,
Inc. Grompe is widely regarded as one of the world's
foremost liver and stem cell authorities. Grompe was
appointed as a Director of the Oregon Stem Cell Center in 2004. "We are proud to have such a noted expert join us.

46th bioscience

Dr. Aristides Patrinos Named President of Synthetic Genomics Inc.

Scientists at the Company , co- led by Dr. Global
Change Research Program (USGCRP), a $2B per year research effort involving
thirteen agencies that addresses the causes and effects of global climate
change. "I am thrilled to be joining Craig
Venter and his talented and multi-disciplinary SGI team as I believe the
company will play an important role in this new scientific revolution. The Company's Scientific Advisory Board is expected to
play an important role in the commercialization of MultiCell's
technology and will assist the Company in pursuing licensing
opportunities. Dr.

biophysical chobe

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)